Related Subjects:
|Hyperuricaemia
|Acute and Chronic Gout
|Allopurinol
Above the threshold of 6.8 mg/dl (410 µmol/l) the risk of serum UA crystallization increases significantly
About
Aetiology
- Increased cell turnover or Reduced excretion
- Urate is poorly solube so precipitates out
- Can happen in renal tubules - urate crystals
Normal Values
- 3.5 to 7.0 mg/dl (208–416 µmol/l) in men and postmenopausal women
- 2.6–5.7 mg/dl (155–339 µmol/l) in premenopausal women
Causes
- Renal failure
- Drugs: Cytotoxins, thiazides, loop diuretics, pyrazinamide.
- Increased cell turnover: Lymphoma, leukaemia, psoriasis, haemolysis
- Cell damage: muscle death (rhabdomyolysis, tumour lysis syndrome)
- Impaired excretion: Gout, CKD, lead nephropathy, hyperparathyroidism, pre-eclampsia
- Lesch–Nyhan syndrome (disorder of purine metabolism)
Clinical
- Underlying condition
- Renal colic
Investigations
- U&E : AKI
- Urate levels: elevated
In critically ill patients in ITU, hyperuricemia is an early marker of the severity of sepsis, as well as a predictor of AKI, ARDS and need for mechanical ventilation use and mortality
Management: Guidelines
- ACR (2012, 2020), 3E Initiative (2014) and EULAR (2016) recommendations for management of hyperuricemia in patients with acute and chronic gout
- Start acute gout treatment in the first 24 hours: Use colchicine p.o. or NSAIDs p.o., or GCS p.o. i.a. as first-line agents in acute gout
- Start ULT only after resolution of acute gout phase; however, if ULT was started before acute gout episode, do not discontinue
- Use long-term ULT only in selected cases, i.e. in case of tophi/ chronic gouty arthropathy
- Use allopurinol, febuxostat and probenecid as first-line agents and pegloticase as a second-line drug
- Start allopurinol at a low dose and gradually escalate to a minimal effective dose
Monitor UA levels during ULT
- Treat to target (until all symptoms’ resolution and UA target level are achieved)
- Maintain UA target level lifelong
- Consider secondary gout prophylaxis with colchicine or NSAIDs
- Screen patients with gout for common comorbidities associated with hyperuricemia
- Prevent High Uriac acid (UA): Allopurinol/Raburicase before chaemotherapy
- Manage Urate induced AKI: IV fluids +/- IV Furosemide to get a good diuresis. If oliguria then consider haemodialysis.
- Renal Urate stones: 10% radiolucent. Commoner in hot climates. Risks are acid/concentrated urine. Commoner with chronic diarrhoea, distal
small bowel disease, ileostomy, obesity, DM, chaemotherapy, dehydration. Needs hydration. Potassium citrate or potassium bicarbonate raise pH > 6.7 dissolves
some urate stones. Consider allopurinol (xanthine oxidase inhibitor).
References